Weekly Newsletter   Challenge account   Weekly Newsletter   

Posted by Martin June 23, 2024

Bristol Myers Squibb Co (BMY) is facing significant challenges, should you invest?

Bristol Myers Squibb Co (BMY) has long been a stalwart in the pharmaceutical industry, renowned for its innovative therapies and robust product pipeline. However, the company is facing a significant challenge with a projected 92% drop in operating earnings for 2024, primarily due to expiring patents on key drugs. This blog post aims to provide Continue reading →